Meng Luo
No. 639 Zhizaoju Road
Huangpu, 200011, China
Huangpu, 200011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Timing of a single dexmedetomidine bolus to attenuate remifentanil-induced hyperalgesia after thyroidectomy: a randomized controlled trial.
Journal: BMC anesthesiology
Published: February 11, 2026
Spermidine-Based Carbon Quantum Dots Alleviate Liver Sinusoidal Endothelial Dysfunction by Inducing LSEC-Derived NO to Ameliorate Hepatic Fibrosis and Portal Hypertension.
Journal: Advanced healthcare materials
Published: October 16, 2025
Evaluation of a 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-induced mouse model in a comparative experimental study of portal hypertension.
Journal: World journal of gastroenterology
Published: September 16, 2025
SGK1 Inhibition Improved Mitochondrial Dysfunction and Astrocyte Senescence in Hepatic Encephalopathy via IL-6/JAK2/STAT3 Signaling Pathway.
Journal: Glia
Published: April 07, 2025
Multifunctional dynamic cerium-polypeptide hydrogel with antibacterial antioxidative anti-inflammatory for multidrug-resistant bacterial infected wound healing.
Journal: Regenerative biomaterials
Published: March 22, 2025
Therapeutic potential of formononetin in cirrhotic portal hypertension: modulating hepatic fibrosis, macrophage polarization, and lymphangiogenesis.
Journal: Frontiers in immunology
Published: February 04, 2025
S-Allyl-Cysteine Ameliorates Cirrhotic Portal Hypertension by Enhancing Lymphangiogenesis via a VEGF-C-Independent Manner.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 08, 2024
Activation of AMP-activated Protein Kinase by Metformin Inhibits Dedifferentiation of Platelet-derived Growth Factor-BB-induced Vascular Smooth Muscle Cells to Improve Arterial Remodeling in Cirrhotic Portal Hypertension.
Journal: Cellular and molecular gastroenterology and hepatology
Published: August 13, 2024
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway.
Journal: World journal of gastroenterology
Published: August 09, 2024
Imperatorin attenuates CCl4-induced cirrhosis and portal hypertension by improving vascular remodeling and profibrogenic pathways.
Journal: European journal of pharmacology
Published: March 18, 2024
Last Updated: 09/26/2026